1. AB0389 The immunogenicity of branded and biosimilar infliximab in rheumatoid arthritis according to th9-related responses. (15th June 2017) Authors: Talotta, R; Berzi, A; Doria, A; Batticciotto, A; Ditto, MC; Trabattoni, D; Puttini, P Sarzi Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1184 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗